RLYB
Rallybio Corp
3월 13일 4:00 PM ET (한국 3/14 05:00)
$9.50
-0.10 ▼ -1.04%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$9.50
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -2.55 | Insider Own | 48.86% | Shs Outstand | 0.01B | Perf Week | -12.92% |
| Market Cap | 0.05B | Forward P/E | - | EPS next Y | -200% | Insider Trans | -0.03% | Shs Float | 0.00B | Perf Month | 99.58% |
| Enterprise Value | -0.01B | PEG | - | EPS next Q | -1.24 | Inst Own | 22.29% | Short Float | 1.64% | Perf Quarter | 54.22% |
| Income | -0.01B | P/S | 75 | EPS this Y | 83.08% | Inst Trans | -0.17% | Short Ratio | 0.37 | Perf Half Y | 100.73% |
| Sales | 0.00B | P/B | 0.79 | EPS next 5Y | - | ROA | -19.32% | Short Interest | 0.04M | Perf YTD | 73.08% |
| Book/sh | 12.02 | P/C | 0.85 | EPS past 3/5Y | 3.21% -19.4% | ROE | -21.17% | 52W High | -17.32% ($11.49) | Perf Year | 81.02% |
| Cash/sh | 11.21 | P/FCF | - | Sales past 3/5Y | - | ROIC | -22.44% | 52W Low | 439.53% ($1.76) | Perf 3Y | -77.68% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 79.93% | Gross Margin | 82.34% | Volatility(W/M) | 8.49% 11.69% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | -13.24 | Sales Y/Y TTM | 12.71% | Oper. Margin | -5172.11% | ATR (14) | 0.82 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 14.74 | EPS Q/Q | 238.24% | Profit Margin | -2102.37% | RSI (14) | 65.46 | Recom | 2.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 14.74 | Sales Q/Q | -29.1% | SMA20 | 19.77% ($7.93) | Beta | -1.21 | Target Price | $8 |
| Payout | - | Debt/Eq | 0 | Earnings | 11000000 | SMA50 | 50.31% ($6.32) | Rel Volume | 0.83 | Prev Close | $9.6 |
| Employees | 25 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 268.75% 217.84% | SMA200 | 95.58% ($4.86) | Avg Volume(3M) | 0.12M | Price | $9.5 |
| IPO | 2021/7/29 | Option/Short | No/Yes | Trades | 1222 | Volume | 99,284 | Change | -1.04% |
뉴스 로딩 중...